Insights on Discovery

  1. Spatial Organization Of The CAR Is Critical For CAR T Cell Function 1/27/2026

    Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.

  2. Psychiatric Drug Development Renaissance: With Familiar Risks 1/6/2026

    Emerging psychiatric therapies bring hope, but progress is fragile. Biomarker-driven, mechanism-first approaches help overcome biological, regulatory, and commercial barriers.

  3. A Strategic Overview Of Fc Engineering 1/5/2026

    Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.

  4. APOEε4: Why Alzheimer's "Prophet" Struggles To Become A Therapeutic "Savior" 1/5/2026

    Explore the technical hurdles of APOE-targeted development and the precision tools—including target proteins and pre-formed fibrils (PFFs)—required to bridge the gap from risk identification to commercial success.

  5. Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site 12/23/2025

    Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.

  6. Preserving Genomic Data's Living Legacy 12/10/2025

    Public genomic datasets like TCGA transformed cancer research, guiding assay validation and cohort design. Today, matched biospecimens complete the loop between digital insight and biological confirmation.

  7. How To Design And Evaluate Bispecific Antibodies (BsAbs)? 11/25/2025

    Bispecific antibodies combine two antigen-binding sites to enhance efficacy and safety. Their design requires structural strategy, MOA-based evaluation, and rigorous screening for optimal therapeutic performance.

  8. Analytical Approach For Bispecific Antibody Quality Study 11/25/2025

    Bispecific antibody quality control demands advanced analytics to detect mispaired species, assess structural integrity, and confirm potency, ensuring safety and efficacy across diverse therapeutic applications.

  9. Empowering Antibody Discovery With ProSpeed™ 11/25/2025

    Integrating linear expression technology into single B cell workflows accelerates antibody discovery, enabling early functional screening, improved sensitivity, and cost-effective identification of diverse therapeutic candidates.

  10. Challenges And Solution In The Poly (A) Control For Plasmid And mRNA 11/25/2025

    Poly(A) tail integrity is critical for mRNA stability and translation. Advanced strategies optimize plasmid design, transcription, and purification to ensure consistent poly(A) control for therapeutic success.